New Century Healthcare Holding Co. Limited (HKG:1518)
Hong Kong · Delayed Price · Currency is HKD 0.8200
-0.0200 (-2.38%)
Jul 24, 2025, 1:02 PM HKT
HKG:1518 Revenue
In the year 2024, New Century Healthcare Holding Co. had annual revenue of 846.50M CNY, down -9.28%. New Century Healthcare Holding Co. had revenue of 430.54M in the half year ending December 31, 2024, with 20.82% growth.
Revenue
846.50M CNY
Revenue Growth
-9.28%
P/S Ratio
0.44
Revenue / Employee
674.50K CNY
Employees
1,255
Market Cap
396.21M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 846.50M | -86.58M | -9.28% |
| Dec 31, 2023 | 933.07M | 296.61M | 46.60% |
| Dec 31, 2022 | 636.46M | 3.89M | 0.62% |
| Dec 31, 2021 | 632.57M | 119.78M | 23.36% |
| Dec 31, 2020 | 512.79M | -216.58M | -29.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |